Paraplegia via hematogenous dissemination of Cunninghamella elegans (mucormycosis) after hematopoietic stem cell transplantation

A 64-year-old man with myelodysplastic syndromes underwent an allogenic bone marrow transplant. He experienced a relapse four months later, and his disease progressed to acute myeloid leukemia. Despite salvage chemotherapy and donor lymphocyte infusion, his disease persisted, and he was admitted for pneumonia (Figure 1A). He was treated with tazobactam/piperacillin. Prophylactic voriconazole was switched to liposomal amphotericin B (L-AMB) (2.5 mg/kg). Cultures, serum β-D-glucan, and Aspergillus galactomannan antigen tests were negative.
Source: International Journal of Infectious Diseases - Category: Infectious Diseases Authors: Tags: Medical Imagery Source Type: research